Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients

Annals of Oncology

Volumn 23, Issue 8, 2012, Pages 1998-2005

  Tafur, A J ^a   Wysokinski, W E ^a   McBane, R D ^a   Wolny, E ^b   Sutkowska, E ^c   Litin, S C ^a   Daniels, P R ^a   Slusser, J P ^a   Hodge, D O ^a   Heit, J A ^a  

^a MAYO CLINIC   (United States)

^b Department of Radiotherapy   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Bleeding; Malignancy; Periprocedural management of anticoagulation; Thromboembolism

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLEEDING; CANCER PATIENT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; THROMBOEMBOLISM; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84864183189     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds058     Document Type: Article

References (17)

1. Waterman AD, Banet G, Milligan PE et al. Patient and physician satisfaction with a telephone-based anticoagulation service. J Gen Intern Med 2001; 16(7): 460-463.
2. Heit JA, Silverstein MD, Mohr DN et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160 (6): 809-815.
3. Chew HK, Wun T, Harvey D et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166 (4): 458-464.
4. Prandoni P, Lensing AWA, Piccioli A et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100 (10): 3484-3488.
5. Hutten B, Prins M, Gent M et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000; 18 (17): 3078-3083.
6. Prandoni P, Trujillo-Santos J, Surico T et al. Recurrent thromboembolism and major bleeding during oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry. Haematologica 2008; 93 (9): 1432-1434.
7. Trujillo-Santos J, Nieto JA, Ruíz-Gamietea A et al. RIETE InvestigatorsBleeding complications associated with anticoagulant therapy in patients with cancer. Thromb Res 2010; 125 Suppl 2: S58-S61.
8. McBane RD, Wysokinski WE, Daniels PR et al. Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol 2010; 30 (3): 442-448.
9. Heit JA, Mohr DN, Silverstein MD et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160 (6): 761-768.
10. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984; 108 (1): 150-158.
11. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3 (4): 692-694.
12. Blom JW, Doggen CJ, Osanto S et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293 (6): 715-722.
13. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002; 87 (4): 575-579.
14. Ashrani AA, Heit JA. Risk factors for thrombosis in cancer patients. Cancer Treat Res 2009; 148: 95-114.
15. Monreal M, Prandoni P, di Micco P et al. Lessons learned from cancer/VTE Registries: report from RIETE. Thromb Res 2007; 120 Suppl 2: S62-S63.
16. Lee AY, Levine MN, Baker RI et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349 (2): 146-153.
17. Elting LS, Escalante CP, Cooksley C et al. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med 2004; 164 (15): 1653-1661.